Digital and Pharma 4.0
Latest content
Anthropic acquires biotech startup exploring AI-led drug development
Anthropic has acquired Mithril Medicine, a biotech startup that used its Claude AI models to coordinate an experimental drug development programme for muscular dystrophy.
Join now
Unlock exclusive industry insights
- Bookmark articles and resources to access anytime
- Enjoy free access to industry leading resources, webinars and insights
- Stay informed with the latest news and breakthroughs in drug discovery
- Receive updates and recommendations tailored to your research interests
Rethinking how investigator oversight is evidenced in clinical trials
As clinical trials grow more complex, evidence of principal investigator oversight requires a more modern, risk-proportionate approach to demonstrate application of clinical and scientific judgment for areas of highest concern in patient safety and data integrity.
European Pharmacopoeia launches working party for 3D-printed medicines
The new group will develop pharmacopoeial quality standards for 3D-printed medicinal products, reflecting the technology’s growing role in personalised medicine manufacturing.
How AI could make formulation development more predictive
Reflections from a recent panel discussion helped to clarify the most valuable application of artificial intelligence to streamline formulation development.
European Pharmaceutical Review Issue 2 2026
EPR Issue 2 includes articles on manufacturing, drug formulation, microbiology, downstream bioprocessing, and more.
Digital and Pharma 4.0
ArticleBuilding the foundation for the orchestrated lab of the future
As pharmaceutical laboratories face mounting pressure to accelerate timelines and manage growing data complexity, intelligent laboratory operations underpin the next generation of connected, autonomous lab environments.
ArticleThermal assurance as an operating model: why the pharmaceutical cold chain must evolve beyond visibility
Real-time monitoring has become standard practice in temperature-controlled distribution. The differentiator now is whether organisations can convert signals into decisions early enough to prevent excursions, reduce waste and strengthen resilience. As Vijay Paliwal, Vice President, Global Advanced Solutions & Customer Experience at Cold Chain Technologies explains, that shift is driving a new operating model for cold chain management: thermal assurance.
ArticleAdopting an AI-driven approach to scale with confidence
Exploring how mid-size pharma can meet European regulatory expectations without rebuilding infrastructure.
OpinionProcess Raman spectroscopy: closing biomanufacturing’s measurement infrastructure gap
The biopharmaceutical industry has embraced Pharma 4.0 concepts, but the measurement infrastructure required to realise autonomous facilities and continuous bioprocessing remains underdeveloped. Process Raman spectroscopy offers continuous, non-destructive monitoring at frequencies aligned with cell culture dynamics, bridging the gap between control system capabilities and available data.